Wells Fargo & Company Cryo Cell International Inc Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CCEL
# of Institutions
16Shares Held
916KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$2.61 Million2.55% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.05 Million0.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA115KShares$729,9940.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$706,1820.03% of portfolio
-
Geode Capital Management, LLC Boston, MA23.7KShares$150,4580.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $54.2M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...